training module for any first-time investigator is a certified GCP training. This includes:

• Overview of ICH E6(R2) guidelines
• PI responsibilities under GCP
• Delegation and supervision
• Subject rights and safety
• Informed consent process
• Essential documents and trial master file (TMF)

GCP training must be documented with a certificate, and many sponsors now require refresher training every two years. Online platforms or sponsor-approved webinars are acceptable if content is validated and completion tracked.

To download GCP training logs and checklists, visit PharmaSOP.in.

Module 2: Protocol and Study Design Familiarization

Study-specific protocol training is essential to ensure that new investigators understand:

• Trial rationale and objectives
• Inclusion/exclusion criteria
• Visit windows and procedures
• Dosing or intervention schedules
• Primary and secondary endpoints

Training should highlight common deviation risks and protocol complexity areas. For example, a misinterpreted inclusion criterion or incorrect lab timing could render a subject non-evaluable. Interactive case-based discussions can help reinforce these points.

It’s recommended that PIs sign a “Protocol Training Acknowledgment Form” as part of their site initiation documentation.

Module 3: Safety Reporting and Pharmacovigilance

Understanding safety reporting obligations is critical for investigators—especially those new to clinical research. This module should address:

• Definition and examples of Adverse Events (AEs) and Serious Adverse Events (SAEs)
• 24-hour reporting requirements for SAEs
• Expedited vs. periodic reporting
• Unblinding procedures and safety management plans
• How to use electronic SAE reporting tools (e.g., E2B-compatible portals)

First-time PIs should be provided with sample SAE forms and instructions for assessing causality and severity. A brief quiz or competency check can help ensure comprehension before the site becomes active.

Module 4: Source Documentation and Data Entry

This module should focus on how to maintain ALCOA+ compliant source documents and how data should be entered into the electronic data capture (EDC) system. Key topics include:

• Defining source data and source records
• How to make corrections (e.g., single line strike-through, initial, date)
• Maintaining audit trails and logs
• Entering data into eCRFs and resolving data queries
• Handling late entries or missing data

Sites should receive a source documentation checklist, and the PI must ensure that all site staff follow these documentation practices consistently. This also includes training on paper versus electronic source integration.

Module 5: Delegation and Oversight Responsibilities

A common finding in FDA inspections is lack of adequate PI oversight. First-time investigators should understand:

• How to complete and maintain a delegation of duties log
• What tasks can or cannot be delegated
• How to document training and supervision of sub-investigators
• How to audit team compliance during the trial

The SOP should require the PI to sign off on all delegation updates and ensure that duties assigned match the individual’s credentials and training records.

Tools to Deliver and Track PI Training

Investigator training can be delivered through a mix of methods:

• Live investigator meetings (virtual or in-person)
• On-demand eLearning platforms (LMS integrated)
• Study-specific training portals
• Interactive webinars with competency quizzes

It’s vital that each training is tracked, with attendance logs, completion certificates, and training records filed in the Trial Master File (TMF) or site regulatory binder. Sponsors must be prepared to present these during inspections.

For FDA inspection readiness, regulators may ask: “When and how was the PI trained on protocol version 2.0?” Your TMF should provide the answer instantly.

Conclusion: Building a Competent and Compliant PI Foundation

First-time investigators bring valuable medical insight to clinical research—but without a structured training program, they risk protocol deviations and regulatory violations. A modular, role-specific training framework ensures they are equipped to conduct trials safely, ethically, and in full compliance with GCP.

Sponsors should maintain a standard PI onboarding SOP, include role-based training modules, and monitor performance continuously throughout the trial.

For downloadable first-time investigator training templates, logs, and protocol acknowledgment forms, visit ClinicalStudies.in or explore ICH E6(R2) for foundational requirements.